O=C(c1cc(COc2ccc(F)cc2F)on1)N1C[C@@H]2C[C@H]3C[C@H]1C[C@H](C3)C2
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?